It's time to apply the same COVID-19 urgency to other devastating diseases, such as Alzheimer’s, write Andrea Pfeifer and William Mobley.
Andrea Pfeifer
Advertisement
Dr. Andrea Pfeifer is Chief Executive Officer and co-founder of AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases.
Articles by Andrea Pfeifer
Advertisement
Latest Updated Articles
- Are We Forgetting to Develop Vaccines for Diseases other than COVID?
Published: June 1st 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
What Impact will DTC Programs have on Generic Drug Prices?
3
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
4
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
5
